Showing results (281-290 of 345) with videos related to

Sort By:
Pageof 35
Drugs|December 19, 2018
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future PerspectivesAura D Herrera-Martínez, Johannes Hofland, Leo J Hofland, et al.
Journal of Endocrinological Investigation|April 22, 2006
Somatostatin-related therapeutics in ophthalmology: a reviewT Missotten, G S Baarsma, R W A M Kuijpers, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Serum Insulin Bioassay Reflects Insulin Sensitivity and Requirements in Type 1 DiabetesJoseph A M J L Janssen, Gemma Llauradó, Aimee J Varewijck, et al.
Molecular and Cellular Endocrinology|August 20, 1990
Effects of suramin on hormone release by cultured rat anterior pituitary cellsH F Marzouk, L J Hofland, F H den Holder, et al.
Frontiers in Endocrinology|May 24, 2023
Epigenetic regulation of SST<sub>2</sub> expression in small intestinal neuroendocrine tumorsMaria J Klomp, Julie Refardt, Peter M van Koetsveld, et al.
Molecular and Cellular Endocrinology|September 18, 2012
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signallingAimee J Varewijck, Michael P Brugts, Jan Frystyk, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 10, 2003
Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cellsVirgil A S H Dalm, P Martin van Hagen, Peter M van Koetsveld, et al.
Molecular and Cellular Endocrinology|May 2, 2006
Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptorCarlotta Gauna, Patric J D Delhanty, Maarten O van Aken, et al.
Molecular Oncology|April 29, 2017
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell linesGiovanni Vitale, Alessandra Dicitore, Daniele Pepe, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2011
Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretionC de Bruin, L J Hofland, L K Nieman, et al.
Pageof 35